Actively Recruiting
Outcomes of Focal Ablation for Prostate Cancer
Led by University of Texas Southwestern Medical Center · Updated on 2026-04-17
225
Participants Needed
1
Research Sites
182 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study will be designed to define the efficacy and safety of ablative therapies in the management of localized prostate cancer and comprehensively evaluate quality of life outcomes and oncologic control following treatment.
CONDITIONS
Official Title
Outcomes of Focal Ablation for Prostate Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male patients with prostate adenocarcinoma confirmed by prostate biopsy
- Male patients with locally recurrent prostate cancer confirmed by biopsy and imaging showing no spread beyond prostate region
- Age between 18 and 90 years
- Life expectancy greater than 1 year
- Able to understand and willing to sign informed consent
You will not qualify if you...
- Anatomical abnormalities preventing focal ablation
- Evidence of prostate cancer extending beyond the prostate making ablation unsuitable
- Active urinary tract infection
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
UTSW
Dallas, Texas, United States, 75390
Actively Recruiting
Research Team
S
Sonobia Garrett
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here